Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Ousted Biolase CEO Federico Pignatelli launches an investigation into the device maker, saying he suspects “wrongdoing, mismanagement and corporate governance failures.” Read more
Edwards Lifesciences says it won 510(k) clearance from the FDA for its ClearSight non-invasive patient monitoring device. Read more
Stryker today said it agreed to acquire a total ankle replacement system developed by Small Bone Innovations, plus finger, wrist and elbow products, for roughly $375 million.
The net cost to Stryker is slated to be roughly $285 million "after taking into account the present value of the tax benefits as a result of the asset purchase structure," the company said. Read more